Email
IZ Express #1,720: CDC releases new COVID-19, updated RSV VISs; new Immunize.org video series, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,720: CDC releases new COVID-19, updated RSV VISs; new Immunize.org video series, and more |
| Date | October 25, 2023 10:16 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,720: October 25, 2023
Top Stories
* CDC releases new COVID-19 mRNA VIS and updated respiratory syncytial virus (RSV) VIS for individuals who are pregnant or age 60 and older
* Immunize.org launches short 6-part Improving the Vaccination Experience Video Series
* Immunize.org posts new Spanish translation of the popular handout "Tips for Locating Old Immunization Records"
* “Use Same Brand of MenB for All Doses”: watch the 2-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram
* Spotlight: Immunize.org resources that focus on vaccine products and manufacturers
* Track the activity of respiratory viruses this season: use CDC’s FluView and RESP-NET surveillance reports, updated weekly
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates screening checklists for 2023–24 influenza vaccines in English and Spanish
* Immunize.org updates patient handout titled "Influenza: Questions and Answers"
* Immunize.org updates "Standing Orders for Administering Hepatitis B Vaccine to Adults"
* Recap: Immunize.org retires four of its resources summarizing recommendations and contraindications
Vaccine Information Statements
* Recap: CDC releases new Immunization Information Statement (IIS) (a VIS-like document) for Respiratory Syncytial Virus (RSV) Preventive Antibody (nirsevimab)
* Recap: Immunize.org posts five new and updated translations of VISs
* Confirm that your VISs are up to date: Immunize.org updates “You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!” and “Dates of Current Vaccine Information Statements (VISs)”
Featured Resources
* CDC posts adorable "Wild to Mild" social media images to promote influenza vaccination
Notable Publications
* HPV vaccine starting at age 9 years: Human Vaccines and Immunotherapeutics publishes 18-article collection on this approach
* “SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022” published in Emerging Infectious Diseases
Upcoming Events
* Today! Virtual: Watch October 25–26 ACIP meeting. Topics include immunization schedules and seven vaccine-preventable diseases.
* Virtual: The National Foundation for Infectious Diseases (NFID) hosts webinar titled “Immunization Recommendations during Pregnancy” on November 2 at 12:00 p.m. (ET)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC releases new COVID-19 mRNA VIS and updated respiratory syncytial virus (RSV) VIS for individuals who are pregnant or age 60 and older
Immunize.org posted two new Vaccine Information Statements (VISs) ([link removed]), published by CDC.
The new COVID-19 mRNA VIS ([link removed]) may be used when vaccinating people age 12 years and older who will receive one of the licensed mRNA vaccines (Comirnaty by Pfizer-BioNTech or Spikevax by Moderna). Because adverse events caused by COVID-19 vaccines are not covered by the Vaccine Injury Compensation Program at this time, use of the VIS is recommended, not required. COVID-19 vaccines remain covered under the Countermeasures Injury Compensation Program ([link removed]) (CICP).
Healthcare providers continue to be required to provide the product-specific Emergency Use Authorization (EUA) Fact Sheet when administering a COVID-19 vaccine under conditions of EUA. EUA Fact Sheets are required when vaccinating children age 6 months through 11 years and before giving Novavax COVID-19 Vaccine (2023–2024 Formula) to any eligible recipient. Current EUA Fact Sheets are listed on Immunize.org’s popular Checklist of Current Versions of U.S. COVID-19 Guidance and Clinic Support Tools. ([link removed])
The respiratory syncytial virus (RSV) VIS, originally issued earlier in 2023 for vaccination of adults age 60 and older, ([link removed]) has been updated with information about the September 2023 ACIP recommendation for RSV vaccination of pregnant people between 32 weeks and 36 weeks and 6 days of gestation. A separate immunization information statement (IIS) ([link removed]) was recently posted by CDC for use with the RSV preventive antibody (nirsivemab) recommended for infants.
As with other VISs, translations will be posted on Immunize.org as they become available from our translation service or from partners who generously donate translations to our repository.
* New! COVID-19 Vaccine VIS ([link removed]) dated October 19, 2023
* Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) dated October 19, 2023
Immunize.org updated its corresponding reference documents related to the use of VISs:
* You Must Provide Patients with Vaccine Information Statements (VISs)—It's Federal Law! ([link removed])
* Dates of Current Vaccine Information Statements (VISs) ([link removed])
Related Links
* Immunize.org: COVID-19 Vaccine VIS ([link removed]) main page
* Immunize.org: COVID-19 Vaccine VIS ([link removed]) (PDF, English)
* Immunize.org: Respiratory Syncytial Virus (RSV) VIS ([link removed]) main page
* Immunize.org: Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) (PDF, English)
* Immunize.org: Respiratory Syncytial Virus (RSV) Preventive Antibody IIS ([link removed]) main page
* Immunize.org: Vaccine Information Statements main page ([link removed]) with VISs in up to 47 languages ([link removed])
* CDC: What's New with VISs ([link removed]) main page
* CDC: Current VISs ([link removed]) main page
------------------------------------------------------------
Immunize.org launches short 6-part Improving the Vaccination Experience Video Series
With special support from CDC, Immunize.org recently launched a series of short videos to introduce you to different ways to improve the vaccination experience for infants, children, teens, and adults. Each video is closed captioned and runs 4 minutes or less. Three are for a general audience, and three are specifically intended for healthcare professionals.
These videos introduce basic principles and orient you to related print-ready resources from Immunize.org for the healthcare team or families. As with all Immunize.org resources, these videos and associated clinical resources are free to download, link, copy, and share.
Over our next six editions, IZ Express will feature each new video and its associated clinical resources. If you don’t want to wait, you can find the entire playlist now on the Immunize.org YouTube channel. ([link removed]) Consider sharing relevant links with the patients you serve on your website or social media channel, or using them in ongoing staff training during clinic huddles or presentations.
The video topics include:
* Addressing Vaccination Anxiety: Strategies for Healthcare Professionals ([link removed])
* Addressing Vaccination Anxiety for Infants: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Fainting Related to Vaccination: What You Need to Know ([link removed])
* Using Enhanced Screening Checklists for Contraindications to Vaccination ([link removed])
* How to Administer Multiple Intramuscular Vaccines to Adults During One Visit ([link removed])
Related Links
* Immunize.org: YouTube channel ([link removed])
* Immunize.org: Handouts for Patients and Staff ([link removed]): Addressing Vaccination Anxiety ([link removed]) main page
* Immunize.org: Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) on-demand webinar (2/28/23)
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) on-demand webinar (12/13/22)
* Immunize.org: Screening Checklists ([link removed]) main page (includes screening checklists with questions to screen for a history of fainting or feeling faint and for vaccination-related anxiety)
------------------------------------------------------------
Immunize.org posts new Spanish translation of the popular handout "Tips for Locating Old Immunization Records"
For the first time, Immunize.org created and posted a Spanish translation of its helpful and popular document for families, titled Tips for Locating Old Immunization Records ([link removed]).
Related Links
* Immunize.org: Handouts: Documenting Vaccination ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
“Use Same Brand of MenB for All Doses”: watch the 2-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram
Immunize.org's social media channels make it easy for you to learn a little more every day. This week, our featured episode from the Ask the Experts Video Series is Use Same Brand of MenB for All Doses ([link removed]). This is available on our YouTube channel ([link removed]), along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* X (Twitter) at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Spotlight: Immunize.org resources that focus on vaccine products and manufacturers
In this week's Spotlight, we summarize resources at Immunize.org that focus on specific vaccine products.
Package Inserts and FDA Product Approvals ([link removed]) main page provides up-to-date product information links and links to FDA vaccine approval web pages for all vaccines licensed for use in the United States.
Vaccine Manufacturers ([link removed]) main page provides links to the websites of the vaccine manufacturers in the United States, as well as providing contact information such as telephone numbers and email addresses. In addition, the vaccine products for each of the companies are listed.
Vaccines ([link removed]) main page links to information about 24 diseases that vaccines can prevent. For each vaccine, access the latest recommendations, information, and resources from Immunize.org and CDC.
------------------------------------------------------------
Track the activity of respiratory viruses this season: use CDC’s FluView and RESP-NET surveillance reports, updated weekly
Influenza, respiratory syncytial virus (RSV), and COVID-19 are circulating at low levels, and CDC expects respiratory virus activity to increase. Influenza activity is currently low nationally with small increases reported in some parts of the country. CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]), provides a valuable snapshot of influenza activity state-by-state.
Influenza Surveillance
For week 41, ending October 14, CDC's Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) shows that, nationwide, 2.3% of patient visits reported through the Outpatient Influenza-Like Illness Surveillance Network (ILINet) were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). This is below the national baseline of 2.5%. One influenza-associated pediatric death that occurred during the 2022–2023 season was reported this week.
RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) ([link removed]) for weekly reports of hospitalizations across the United States due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV.
Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard ([link removed]) data show that 116 million doses of influenza vaccine were shipped within the United States through September 30, 2023.
CDC recommends everyone age 6 months and older get annual influenza vaccination. Influenza and other vaccines (e.g., COVID-19 vaccine, RSV vaccine) may be given at the same visit, if needed. Locate influenza and COVID-19 vaccines in your area by entering your zip code in the VaccineFinder on Vaccines.gov ([link removed]) or Vacunas.gov ([link removed]). To be listed as a provider by VaccineFinder, see the information on this website ([link removed]).
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Associated Press: RFK Jr. Spent Years Stoking Fear and Mistrust of Vaccines. These People Were Hurt by His Work ([link removed]) (10/18/23)
* Washington Post: RSV Is America’s Leading Cause of Hospitalization for Children under 5 ([link removed])(10/16/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates screening checklists for 2023–24 influenza vaccines in English and Spanish
After receiving questions concerning egg allergy and influenza vaccination, Immunize.org revised the wording of its screening checklists for the 2023–24 influenza season to simplify and clarify the statement that egg allergy of any severity is neither a contraindication nor a precaution to the use of any influenza vaccine.
* Screening checklist for contraindications to inactivated injectable influenza vaccination: view in English ([link removed]) or in Spanish ([link removed])
* Screening checklist for contraindications to live attenuated intranasal influenza vaccination: view in English ([link removed]) or in Spanish ([link removed])
See all the Immunize.org screening checklists by going to the Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page. Update your screening checklists today.
[link removed]
Related Links
* Immunize.org: Screening Checklist ([link removed]) main page (showing language options)
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
------------------------------------------------------------
Immunize.org updates patient handout titled "Influenza: Questions and Answers"
Immunize.org recently updated its resource for the public: Influenza: Questions and Answers ([link removed]). The document now includes updated information for the 2023–24 influenza season.
Related Links
* Immunize.org: Influenza: Questions and Answers ([link removed]) main page
* Immunize.org: Handouts: Q&As: Diseases and Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 240 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates "Standing Orders for Administering Hepatitis B Vaccine to Adults"
Immunize.org updated Standing Orders for Administering Hepatitis B Vaccine to Adults ([link removed]). Changes include new information about routine serologic testing for hepatitis B in adults, and a clarification about vaccine brand options and dose intervals for people whose first dose was of an unknown brand.
[link removed]
Related Links
* Immunize.org: Standing Orders Templates for Administering Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Recap: Immunize.org retires four of its resources summarizing recommendations and contraindications
After many years as valuable and popular references, Immunize.org retired four of its more than 230 resources for healthcare professionals. The CDC child/adolescent and adult recommended immunization schedules ([link removed]) now incorporate detailed clinical notes and list the contraindications and precautions for vaccines on the schedule. In addition, CDC schedules are now updated online more frequently, as new ACIP recommendations and changes to the schedules are made. As a result, the following Immunize.org documents were retired as redundant and users are referred to the CDC schedules ([link removed]) for the information:
* Summary of Recommendations for Child/Teen Immunization (Age birth through 18 years)
* Summary of Recommendations for Adult Immunization (Age 19 years and older)
* Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults
* Guide to Contraindications and Precautions to Commonly Used Vaccines for All Ages
Immunize.org remains focused on connecting healthcare professionals with the resources you need to achieve excellence in your immunization practice.
Related Link
* CDC: Recommended Immunization Schedules ([link removed]) main page
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Recap: CDC releases new Immunization Information Statement (IIS) (a VIS-like document) for Respiratory Syncytial Virus (RSV) Preventive Antibody (nirsevimab)
On September 25, CDC released a new Immunization Information Statement (IIS) (similar in format to a Vaccine Information Statement [VIS]), for Respiratory Syncytial Virus (RSV) Preventive Antibody ([link removed]) (nirsevimab). This IIS document contains important information about the new preventive antibody product for families. Access the IIS in PDF ([link removed]) or RTF file ([link removed]) (for use in electronic systems).
Immunize.org added the Immunization Information Statement (IIS): Respiratory Syncytial Virus (RSV) Preventive Antibody ([link removed]) to our website and will provide translations in the future.
[link removed]
At this time, the RSV preventive antibody is not part of the Vaccine Injury Compensation Program (VICP); therefore, use of the IIS is not required by federal law. However, as a condition of participating in the Vaccines for Children (VFC) program, providers must give the IIS to parents in the same way that a VIS is provided.
Related Links
* CDC: Respiratory Syncytial Virus (RSV) Preventive Antibody: Immunization Information Statement (IIS) ([link removed]) web page
* CDC: Respiratory Syncytial Virus (RSV) Immunizations ([link removed]) web page
* Immunize.org: Immunization Information Statement (IIS): Respiratory Syncytial Virus (RSV) Preventive Antibody ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
------------------------------------------------------------
Recap: Immunize.org posts five new and updated translations of VISs
IZ Express regularly provides readers with information about new and updated Vaccine Information Statements (VISs) and their translations.
On July 24, CDC released an updated interim VIS for Pediatric Multi-vaccines (Your Child's First Vaccines) ([link removed]) and on May 12, CDC released interim VISs for Hepatitis B Vaccine ([link removed]) and Pneumococcal Conjugate (PCV) Vaccine ([link removed]). Immunize.org recently posted two new translations for each, generously donated by St. Peter's Health Partners of Albany, NY.
Hepatitis B Vaccine (view in English ([link removed])):
* Burmese ([link removed])
* Karen ([link removed])
Pneumococcal Conjugate Vaccine (view in English ([link removed])):
* Burmese ([link removed])
* Karen ([link removed])
Your Child’s First Vaccines (view in English ([link removed])):
* New! Karen ([link removed])
Related Links
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Confirm that your VISs are up to date: Immunize.org updates “You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!” and “Dates of Current Vaccine Information Statements (VISs)”
In response to the Vaccine Information Statements (VISs) released by CDC on October 19, Immunize.org updated its two provider resources about VISs with the publication date of the new Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) and updated COVID-19 Vaccine VIS ([link removed]).
* You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed]) (2 pages)
* Dates of Current Vaccine Information Statements (VISs) ([link removed])
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
CDC posts adorable "Wild to Mild" social media images to promote influenza vaccination
CDC's Wild to Mild ([link removed]) social media images are a lighthearted way to promote influenza vaccination. Encourage your patients, friends, loved ones, and followers on social media to get themselves and their families an annual influenza vaccine with the resources below. CDC's toolkit will be updated soon to include customizable graphic frames you can add to your photos, sample social media graphics, and printable materials.
Download one of the social media graphics below and share on Twitter, Instagram, or Facebook.
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
HPV vaccine starting at age 9 years: Human Vaccines and Immunotherapeutics publishes 18-article collection on this approach
Despite the effectiveness of HPV vaccination at preventing HPV-related cancers and other diseases, HPV vaccination rates in the United States lag those for other adolescent vaccinations. Starting HPV vaccination at age 9 or 10 years might improve vaccination uptake and increase the number of adolescents who complete their series on time.
Human Vaccines and Immunotherapeutics published an open-access collection of 18 original papers ([link removed]) on the effect of starting HPV vaccination before age 11 years. The collection, co-edited by Immunize.org’s director for research Sharon Humiston, MD, MPH, includes articles on population studies and quality-improvement projects, as well as commentaries from medical organizations and leading experts in the field.
To view all the articles in this collection, see Human Vaccines and Immunotherapeutics: HPV Vaccination Starting at Age 9 ([link removed]).
------------------------------------------------------------
“SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022” published in Emerging Infectious Diseases
In the October issue, Emerging Infectious Diseases published SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022 ([link removed]). A portion of the abstract appears below.
To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult residents of Chicago, Illinois, USA, with SARS-CoV-2 longitudinally from their first reported infection through May 31, 2022. . . . Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH [Persons with HIV] and 23,642/450,701 (5%) persons without HIV [PWOH]. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57–77] cases/1,000 person-years) than PWOH (50 [95% CI 49–51] cases/1,000 person-years). PWH had a higher adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27–1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.
PWH = Persons with HIV; PWOH = Persons without HIV
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today! Virtual: Watch October 25–26 ACIP meeting. Topics include immunization schedules and seven vaccine-preventable diseases.
CDC will convene a 2-day meeting of the Advisory Committee on Immunization Practices ([link removed]) (ACIP) today, October 25, starting at 8:00 a.m. (ET). ACIP will discuss child and adolescent immunization schedules, adult immunization schedule, influenza, chikungunya, COVID–19, meningococcal, mpox, and pneumococcal vaccines, as well as RSV vaccines for older adults. Votes on immunization schedules, meningococcal vaccines, and mpox vaccine are scheduled.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described on the website.
View the agenda ([link removed]).
Related Links
* CDC: ACIP main page ([link removed]) for access to webcast, agendas
* CDC: ACIP: Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
------------------------------------------------------------
Virtual: The National Foundation for Infectious Diseases (NFID) hosts webinar titled “Immunization Recommendations during Pregnancy” on November 2 at 12:00 p.m. (ET)
The National Foundation of Infectious Diseases (NFID) will host a webinar titled Immunization Recommendations during Pregnancy ([link removed]), 12:00–1:15 p.m. (ET) on November 2. This interactive panel, featuring experts from the NFID, American College of Obstetricians and Gynecologists (ACOG), and Society for Maternal-Fetal Medicine (SMFM), will include a discussion on recommended vaccination during pregnancy. Speakers will discuss Tdap, COVID-19, influenza, and recent updates in respiratory syncytial virus (RSV) immunization recommendations.
There is no fee to participate in this activity, but preregistration is required.
Register for the webinar ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,720: October 25, 2023
Top Stories
* CDC releases new COVID-19 mRNA VIS and updated respiratory syncytial virus (RSV) VIS for individuals who are pregnant or age 60 and older
* Immunize.org launches short 6-part Improving the Vaccination Experience Video Series
* Immunize.org posts new Spanish translation of the popular handout "Tips for Locating Old Immunization Records"
* “Use Same Brand of MenB for All Doses”: watch the 2-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram
* Spotlight: Immunize.org resources that focus on vaccine products and manufacturers
* Track the activity of respiratory viruses this season: use CDC’s FluView and RESP-NET surveillance reports, updated weekly
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates screening checklists for 2023–24 influenza vaccines in English and Spanish
* Immunize.org updates patient handout titled "Influenza: Questions and Answers"
* Immunize.org updates "Standing Orders for Administering Hepatitis B Vaccine to Adults"
* Recap: Immunize.org retires four of its resources summarizing recommendations and contraindications
Vaccine Information Statements
* Recap: CDC releases new Immunization Information Statement (IIS) (a VIS-like document) for Respiratory Syncytial Virus (RSV) Preventive Antibody (nirsevimab)
* Recap: Immunize.org posts five new and updated translations of VISs
* Confirm that your VISs are up to date: Immunize.org updates “You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!” and “Dates of Current Vaccine Information Statements (VISs)”
Featured Resources
* CDC posts adorable "Wild to Mild" social media images to promote influenza vaccination
Notable Publications
* HPV vaccine starting at age 9 years: Human Vaccines and Immunotherapeutics publishes 18-article collection on this approach
* “SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022” published in Emerging Infectious Diseases
Upcoming Events
* Today! Virtual: Watch October 25–26 ACIP meeting. Topics include immunization schedules and seven vaccine-preventable diseases.
* Virtual: The National Foundation for Infectious Diseases (NFID) hosts webinar titled “Immunization Recommendations during Pregnancy” on November 2 at 12:00 p.m. (ET)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC releases new COVID-19 mRNA VIS and updated respiratory syncytial virus (RSV) VIS for individuals who are pregnant or age 60 and older
Immunize.org posted two new Vaccine Information Statements (VISs) ([link removed]), published by CDC.
The new COVID-19 mRNA VIS ([link removed]) may be used when vaccinating people age 12 years and older who will receive one of the licensed mRNA vaccines (Comirnaty by Pfizer-BioNTech or Spikevax by Moderna). Because adverse events caused by COVID-19 vaccines are not covered by the Vaccine Injury Compensation Program at this time, use of the VIS is recommended, not required. COVID-19 vaccines remain covered under the Countermeasures Injury Compensation Program ([link removed]) (CICP).
Healthcare providers continue to be required to provide the product-specific Emergency Use Authorization (EUA) Fact Sheet when administering a COVID-19 vaccine under conditions of EUA. EUA Fact Sheets are required when vaccinating children age 6 months through 11 years and before giving Novavax COVID-19 Vaccine (2023–2024 Formula) to any eligible recipient. Current EUA Fact Sheets are listed on Immunize.org’s popular Checklist of Current Versions of U.S. COVID-19 Guidance and Clinic Support Tools. ([link removed])
The respiratory syncytial virus (RSV) VIS, originally issued earlier in 2023 for vaccination of adults age 60 and older, ([link removed]) has been updated with information about the September 2023 ACIP recommendation for RSV vaccination of pregnant people between 32 weeks and 36 weeks and 6 days of gestation. A separate immunization information statement (IIS) ([link removed]) was recently posted by CDC for use with the RSV preventive antibody (nirsivemab) recommended for infants.
As with other VISs, translations will be posted on Immunize.org as they become available from our translation service or from partners who generously donate translations to our repository.
* New! COVID-19 Vaccine VIS ([link removed]) dated October 19, 2023
* Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) dated October 19, 2023
Immunize.org updated its corresponding reference documents related to the use of VISs:
* You Must Provide Patients with Vaccine Information Statements (VISs)—It's Federal Law! ([link removed])
* Dates of Current Vaccine Information Statements (VISs) ([link removed])
Related Links
* Immunize.org: COVID-19 Vaccine VIS ([link removed]) main page
* Immunize.org: COVID-19 Vaccine VIS ([link removed]) (PDF, English)
* Immunize.org: Respiratory Syncytial Virus (RSV) VIS ([link removed]) main page
* Immunize.org: Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) (PDF, English)
* Immunize.org: Respiratory Syncytial Virus (RSV) Preventive Antibody IIS ([link removed]) main page
* Immunize.org: Vaccine Information Statements main page ([link removed]) with VISs in up to 47 languages ([link removed])
* CDC: What's New with VISs ([link removed]) main page
* CDC: Current VISs ([link removed]) main page
------------------------------------------------------------
Immunize.org launches short 6-part Improving the Vaccination Experience Video Series
With special support from CDC, Immunize.org recently launched a series of short videos to introduce you to different ways to improve the vaccination experience for infants, children, teens, and adults. Each video is closed captioned and runs 4 minutes or less. Three are for a general audience, and three are specifically intended for healthcare professionals.
These videos introduce basic principles and orient you to related print-ready resources from Immunize.org for the healthcare team or families. As with all Immunize.org resources, these videos and associated clinical resources are free to download, link, copy, and share.
Over our next six editions, IZ Express will feature each new video and its associated clinical resources. If you don’t want to wait, you can find the entire playlist now on the Immunize.org YouTube channel. ([link removed]) Consider sharing relevant links with the patients you serve on your website or social media channel, or using them in ongoing staff training during clinic huddles or presentations.
The video topics include:
* Addressing Vaccination Anxiety: Strategies for Healthcare Professionals ([link removed])
* Addressing Vaccination Anxiety for Infants: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Fainting Related to Vaccination: What You Need to Know ([link removed])
* Using Enhanced Screening Checklists for Contraindications to Vaccination ([link removed])
* How to Administer Multiple Intramuscular Vaccines to Adults During One Visit ([link removed])
Related Links
* Immunize.org: YouTube channel ([link removed])
* Immunize.org: Handouts for Patients and Staff ([link removed]): Addressing Vaccination Anxiety ([link removed]) main page
* Immunize.org: Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) on-demand webinar (2/28/23)
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) on-demand webinar (12/13/22)
* Immunize.org: Screening Checklists ([link removed]) main page (includes screening checklists with questions to screen for a history of fainting or feeling faint and for vaccination-related anxiety)
------------------------------------------------------------
Immunize.org posts new Spanish translation of the popular handout "Tips for Locating Old Immunization Records"
For the first time, Immunize.org created and posted a Spanish translation of its helpful and popular document for families, titled Tips for Locating Old Immunization Records ([link removed]).
Related Links
* Immunize.org: Handouts: Documenting Vaccination ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
“Use Same Brand of MenB for All Doses”: watch the 2-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram
Immunize.org's social media channels make it easy for you to learn a little more every day. This week, our featured episode from the Ask the Experts Video Series is Use Same Brand of MenB for All Doses ([link removed]). This is available on our YouTube channel ([link removed]), along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* X (Twitter) at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Spotlight: Immunize.org resources that focus on vaccine products and manufacturers
In this week's Spotlight, we summarize resources at Immunize.org that focus on specific vaccine products.
Package Inserts and FDA Product Approvals ([link removed]) main page provides up-to-date product information links and links to FDA vaccine approval web pages for all vaccines licensed for use in the United States.
Vaccine Manufacturers ([link removed]) main page provides links to the websites of the vaccine manufacturers in the United States, as well as providing contact information such as telephone numbers and email addresses. In addition, the vaccine products for each of the companies are listed.
Vaccines ([link removed]) main page links to information about 24 diseases that vaccines can prevent. For each vaccine, access the latest recommendations, information, and resources from Immunize.org and CDC.
------------------------------------------------------------
Track the activity of respiratory viruses this season: use CDC’s FluView and RESP-NET surveillance reports, updated weekly
Influenza, respiratory syncytial virus (RSV), and COVID-19 are circulating at low levels, and CDC expects respiratory virus activity to increase. Influenza activity is currently low nationally with small increases reported in some parts of the country. CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]), provides a valuable snapshot of influenza activity state-by-state.
Influenza Surveillance
For week 41, ending October 14, CDC's Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) shows that, nationwide, 2.3% of patient visits reported through the Outpatient Influenza-Like Illness Surveillance Network (ILINet) were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). This is below the national baseline of 2.5%. One influenza-associated pediatric death that occurred during the 2022–2023 season was reported this week.
RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) ([link removed]) for weekly reports of hospitalizations across the United States due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV.
Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard ([link removed]) data show that 116 million doses of influenza vaccine were shipped within the United States through September 30, 2023.
CDC recommends everyone age 6 months and older get annual influenza vaccination. Influenza and other vaccines (e.g., COVID-19 vaccine, RSV vaccine) may be given at the same visit, if needed. Locate influenza and COVID-19 vaccines in your area by entering your zip code in the VaccineFinder on Vaccines.gov ([link removed]) or Vacunas.gov ([link removed]). To be listed as a provider by VaccineFinder, see the information on this website ([link removed]).
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Associated Press: RFK Jr. Spent Years Stoking Fear and Mistrust of Vaccines. These People Were Hurt by His Work ([link removed]) (10/18/23)
* Washington Post: RSV Is America’s Leading Cause of Hospitalization for Children under 5 ([link removed])(10/16/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates screening checklists for 2023–24 influenza vaccines in English and Spanish
After receiving questions concerning egg allergy and influenza vaccination, Immunize.org revised the wording of its screening checklists for the 2023–24 influenza season to simplify and clarify the statement that egg allergy of any severity is neither a contraindication nor a precaution to the use of any influenza vaccine.
* Screening checklist for contraindications to inactivated injectable influenza vaccination: view in English ([link removed]) or in Spanish ([link removed])
* Screening checklist for contraindications to live attenuated intranasal influenza vaccination: view in English ([link removed]) or in Spanish ([link removed])
See all the Immunize.org screening checklists by going to the Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page. Update your screening checklists today.
[link removed]
Related Links
* Immunize.org: Screening Checklist ([link removed]) main page (showing language options)
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
------------------------------------------------------------
Immunize.org updates patient handout titled "Influenza: Questions and Answers"
Immunize.org recently updated its resource for the public: Influenza: Questions and Answers ([link removed]). The document now includes updated information for the 2023–24 influenza season.
Related Links
* Immunize.org: Influenza: Questions and Answers ([link removed]) main page
* Immunize.org: Handouts: Q&As: Diseases and Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 240 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates "Standing Orders for Administering Hepatitis B Vaccine to Adults"
Immunize.org updated Standing Orders for Administering Hepatitis B Vaccine to Adults ([link removed]). Changes include new information about routine serologic testing for hepatitis B in adults, and a clarification about vaccine brand options and dose intervals for people whose first dose was of an unknown brand.
[link removed]
Related Links
* Immunize.org: Standing Orders Templates for Administering Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Recap: Immunize.org retires four of its resources summarizing recommendations and contraindications
After many years as valuable and popular references, Immunize.org retired four of its more than 230 resources for healthcare professionals. The CDC child/adolescent and adult recommended immunization schedules ([link removed]) now incorporate detailed clinical notes and list the contraindications and precautions for vaccines on the schedule. In addition, CDC schedules are now updated online more frequently, as new ACIP recommendations and changes to the schedules are made. As a result, the following Immunize.org documents were retired as redundant and users are referred to the CDC schedules ([link removed]) for the information:
* Summary of Recommendations for Child/Teen Immunization (Age birth through 18 years)
* Summary of Recommendations for Adult Immunization (Age 19 years and older)
* Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults
* Guide to Contraindications and Precautions to Commonly Used Vaccines for All Ages
Immunize.org remains focused on connecting healthcare professionals with the resources you need to achieve excellence in your immunization practice.
Related Link
* CDC: Recommended Immunization Schedules ([link removed]) main page
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Recap: CDC releases new Immunization Information Statement (IIS) (a VIS-like document) for Respiratory Syncytial Virus (RSV) Preventive Antibody (nirsevimab)
On September 25, CDC released a new Immunization Information Statement (IIS) (similar in format to a Vaccine Information Statement [VIS]), for Respiratory Syncytial Virus (RSV) Preventive Antibody ([link removed]) (nirsevimab). This IIS document contains important information about the new preventive antibody product for families. Access the IIS in PDF ([link removed]) or RTF file ([link removed]) (for use in electronic systems).
Immunize.org added the Immunization Information Statement (IIS): Respiratory Syncytial Virus (RSV) Preventive Antibody ([link removed]) to our website and will provide translations in the future.
[link removed]
At this time, the RSV preventive antibody is not part of the Vaccine Injury Compensation Program (VICP); therefore, use of the IIS is not required by federal law. However, as a condition of participating in the Vaccines for Children (VFC) program, providers must give the IIS to parents in the same way that a VIS is provided.
Related Links
* CDC: Respiratory Syncytial Virus (RSV) Preventive Antibody: Immunization Information Statement (IIS) ([link removed]) web page
* CDC: Respiratory Syncytial Virus (RSV) Immunizations ([link removed]) web page
* Immunize.org: Immunization Information Statement (IIS): Respiratory Syncytial Virus (RSV) Preventive Antibody ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
------------------------------------------------------------
Recap: Immunize.org posts five new and updated translations of VISs
IZ Express regularly provides readers with information about new and updated Vaccine Information Statements (VISs) and their translations.
On July 24, CDC released an updated interim VIS for Pediatric Multi-vaccines (Your Child's First Vaccines) ([link removed]) and on May 12, CDC released interim VISs for Hepatitis B Vaccine ([link removed]) and Pneumococcal Conjugate (PCV) Vaccine ([link removed]). Immunize.org recently posted two new translations for each, generously donated by St. Peter's Health Partners of Albany, NY.
Hepatitis B Vaccine (view in English ([link removed])):
* Burmese ([link removed])
* Karen ([link removed])
Pneumococcal Conjugate Vaccine (view in English ([link removed])):
* Burmese ([link removed])
* Karen ([link removed])
Your Child’s First Vaccines (view in English ([link removed])):
* New! Karen ([link removed])
Related Links
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Confirm that your VISs are up to date: Immunize.org updates “You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!” and “Dates of Current Vaccine Information Statements (VISs)”
In response to the Vaccine Information Statements (VISs) released by CDC on October 19, Immunize.org updated its two provider resources about VISs with the publication date of the new Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) and updated COVID-19 Vaccine VIS ([link removed]).
* You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed]) (2 pages)
* Dates of Current Vaccine Information Statements (VISs) ([link removed])
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
CDC posts adorable "Wild to Mild" social media images to promote influenza vaccination
CDC's Wild to Mild ([link removed]) social media images are a lighthearted way to promote influenza vaccination. Encourage your patients, friends, loved ones, and followers on social media to get themselves and their families an annual influenza vaccine with the resources below. CDC's toolkit will be updated soon to include customizable graphic frames you can add to your photos, sample social media graphics, and printable materials.
Download one of the social media graphics below and share on Twitter, Instagram, or Facebook.
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
HPV vaccine starting at age 9 years: Human Vaccines and Immunotherapeutics publishes 18-article collection on this approach
Despite the effectiveness of HPV vaccination at preventing HPV-related cancers and other diseases, HPV vaccination rates in the United States lag those for other adolescent vaccinations. Starting HPV vaccination at age 9 or 10 years might improve vaccination uptake and increase the number of adolescents who complete their series on time.
Human Vaccines and Immunotherapeutics published an open-access collection of 18 original papers ([link removed]) on the effect of starting HPV vaccination before age 11 years. The collection, co-edited by Immunize.org’s director for research Sharon Humiston, MD, MPH, includes articles on population studies and quality-improvement projects, as well as commentaries from medical organizations and leading experts in the field.
To view all the articles in this collection, see Human Vaccines and Immunotherapeutics: HPV Vaccination Starting at Age 9 ([link removed]).
------------------------------------------------------------
“SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022” published in Emerging Infectious Diseases
In the October issue, Emerging Infectious Diseases published SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022 ([link removed]). A portion of the abstract appears below.
To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult residents of Chicago, Illinois, USA, with SARS-CoV-2 longitudinally from their first reported infection through May 31, 2022. . . . Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH [Persons with HIV] and 23,642/450,701 (5%) persons without HIV [PWOH]. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57–77] cases/1,000 person-years) than PWOH (50 [95% CI 49–51] cases/1,000 person-years). PWH had a higher adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27–1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.
PWH = Persons with HIV; PWOH = Persons without HIV
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today! Virtual: Watch October 25–26 ACIP meeting. Topics include immunization schedules and seven vaccine-preventable diseases.
CDC will convene a 2-day meeting of the Advisory Committee on Immunization Practices ([link removed]) (ACIP) today, October 25, starting at 8:00 a.m. (ET). ACIP will discuss child and adolescent immunization schedules, adult immunization schedule, influenza, chikungunya, COVID–19, meningococcal, mpox, and pneumococcal vaccines, as well as RSV vaccines for older adults. Votes on immunization schedules, meningococcal vaccines, and mpox vaccine are scheduled.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described on the website.
View the agenda ([link removed]).
Related Links
* CDC: ACIP main page ([link removed]) for access to webcast, agendas
* CDC: ACIP: Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
------------------------------------------------------------
Virtual: The National Foundation for Infectious Diseases (NFID) hosts webinar titled “Immunization Recommendations during Pregnancy” on November 2 at 12:00 p.m. (ET)
The National Foundation of Infectious Diseases (NFID) will host a webinar titled Immunization Recommendations during Pregnancy ([link removed]), 12:00–1:15 p.m. (ET) on November 2. This interactive panel, featuring experts from the NFID, American College of Obstetricians and Gynecologists (ACOG), and Society for Maternal-Fetal Medicine (SMFM), will include a discussion on recommended vaccination during pregnancy. Speakers will discuss Tdap, COVID-19, influenza, and recent updates in respiratory syncytial virus (RSV) immunization recommendations.
There is no fee to participate in this activity, but preregistration is required.
Register for the webinar ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp